SafeHeal

Paris, France

SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.

$39.9M raised

Apr 2025

Series C

Top Investors

Sofinnova PartnersGenesis MedtechGideon Strategic PartnersM&L Healthcare InvestmentsMedTech Innovator

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has SafeHeal raised?

SafeHeal has raised $39.9M in total funding. The most recent round was Series C. The last funding was announced in April 2025.

Who are SafeHeal's investors?

SafeHeal's investors include Sofinnova Partners, Genesis Medtech, Gideon Strategic Partners, M&L Healthcare Investments, MedTech Innovator.

Where is SafeHeal headquartered?

SafeHeal is headquartered in Paris, France.

What does SafeHeal do?

SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.

What stage is SafeHeal at?

SafeHeal is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 29, 2025.

MLA

"SafeHeal — Funding & Investors." VCBacked, April 29, 2025, https://www.vcbacked.co/company/safeheal. Accessed June 4, 2026.

APA

VCBacked. (2025). SafeHeal — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/safeheal

Wikipedia (cite web)

{{cite web |title=SafeHeal — Funding & Investors |url=https://www.vcbacked.co/company/safeheal |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 29, 2025.